A Study Comparing Proponent Solution - Nasal Spray (PSNS) With Salt Water for Treating Nasal Congestion Symptoms in Adults With Rebound Nasal Congestion While Weaning From Nasal Decongestant Sprays

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

February 25, 2024

Primary Completion Date

July 24, 2024

Study Completion Date

July 24, 2024

Conditions
Rhinitis Medicamentosa
Interventions
DEVICE

PSNS

The nasal spray was self-administered by study subjects at a maximum daily dose of 16 puffs per day, distributed over 1-2 puffs per nostril 2-4 times per day, depending on symptom severity and their alleviation.

DEVICE

ISNS

The nasal spray was self-administered by study subjects at a maximum daily dose of 16 puffs per day, distributed over 1-2 puffs per nostril 2-4 times per day, depending on symptom severity and their alleviation.

Trial Locations (7)

2317

Stortorget Øre Nese Hals AS, Hamar

2860

Hov Legesenter, Hov

3420

Heiaklinikken Legesenter, Helsehuset Lierskogen, Lierskogen

4020

Stavanger Øre-Nese-Hals, Stavanger

4615

Sørlandet Sykehus, Kristiansand, Department for Ear, Nose and Throat, Kristiansand

5021

Haukeland Universitetssykehus, Departments of Otolaryngology and Head and Neck Surgery, Helse Bergen, Bergen

6003

Bjørge Øre-Nese-Hals, Ålesund

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Proponent Biotech GmbH

UNKNOWN

lead

Pharma Nordic AS

INDUSTRY

NCT06817967 - A Study Comparing Proponent Solution - Nasal Spray (PSNS) With Salt Water for Treating Nasal Congestion Symptoms in Adults With Rebound Nasal Congestion While Weaning From Nasal Decongestant Sprays | Biotech Hunter | Biotech Hunter